Amwell reports Q3 2026 loss, beats revenue, and raises 2026 outlook

American Well Corp posted third‑quarter 2026 revenue of $49 million, down about 13% year‑over‑year, and a diluted loss per share of $0.67. The company announced Q4 2026 revenue guidance of $48‑$50 million and expects adjusted EBITDA to break even or turn positive. It also lifted its full‑year 2026 revenue outlook to $204‑$206 million and highlighted a non‑binding letter of intent from the U.S. Department of Veterans Affairs.

The raised revenue and EBITDA guidance suggest a path toward profitability, which may improve cash‑flow expectations for investors (the company said it aims for positive cash flow for the year). The VA letter of intent could add a sizable government contract if finalized, potentially expanding the customer base.

  • 1Q3 2026 revenue was $49.0 million, down 13.0% from $56.3 million a year earlier.
  • 2Net loss attributable to the company was $11.4 million, compared with $32.4 million in the prior‑year quarter.
  • 3Diluted loss per share was ($0.67), versus ($2.00) in the prior‑year quarter.
  • 4Q4 2026 revenue is forecast at $48 million‑$50 million.
  • 5Adjusted EBITDA for Q4 2026 is expected to break even or turn positive.
  • 6Full‑year 2026 revenue outlook is now $204 million‑$206 million.

Sources